pentobarbital will reduce the extent or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers may perhaps decrease partiaprevir and ritonavir stages, and thus diminished efficacy of Viekira